يعرض 1 - 10 نتائج من 20 نتيجة بحث عن '"Inge Van Der Werf"', وقت الاستعلام: 1.22s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4

    المساهمون: Hematology laboratory, AII - Cancer immunology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, Pediatrics, CCA - Cancer Treatment and quality of life

    المصدر: Cell reports. Medicine, vol 4, iss 3
    Cell reports. Medicine, 4(3):100962. Cell Press
    Cell Reports Medicine, 4(3):100962. Cell Press
    van der Werf, I, Mondala, P K, Steel, S K, Balaian, L, Ladel, L, Mason, C N, Diep, R H, Pham, J, Cloos, J, Kaspers, G J L, Chan, W C, Mark, A, la Clair, J J, Wentworth, P, Fisch, K M, Crews, L A, Whisenant, T C, Burkart, M D, Donohoe, M E & Jamieson, C H M 2023, ' Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells ', Cell reports. Medicine, vol. 4, no. 3, 100962, pp. 100962 . https://doi.org/10.1016/j.xcrm.2023.100962, https://doi.org/10.1016/j.xcrm.2023.100962

    وصف الملف: application/pdf

  5. 5
  6. 6
  7. 7

    المساهمون: Hematology, VU University medical center, Hematology laboratory, CCA - Cancer biology and immunology, Epidemiology and Data Science, APH - Methodology, APH - Personalized Medicine, CCA - Cancer Treatment and quality of life

    المصدر: van der Werf, I, Wojtuszkiewicz, A, Meggendorfer, M, Hutter, S, Baer, C, Heymans, M, Valk, P J M, Kern, W, Haferlach, C, Janssen, J J W M, Ossenkoppele, G J, Cloos, J & Haferlach, T 2021, ' Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification ', Blood, vol. 5, no. 17, pp. 3254-3265 . https://doi.org/10.1182/BLOODADVANCES.2021004556
    Blood advances, 5(17), 3254-3265. American Society of Hematology
    Blood Adv
    Blood, 5(17), 3254-3265. American Society of Hematology

  8. 8

    المساهمون: CCA - Cancer biology and immunology, VU University medical center, Hematology laboratory, Hematology, Rheumatology, Pediatric surgery, AII - Cancer immunology

    المصدر: Leukemia
    van der Werf, I, Wojtuszkiewicz, A, Yao, H, Sciarrillo, R, Meggendorfer, M, Hutter, S, Walter, W, Janssen, J, Kern, W, Haferlach, C, Haferlach, T, Jansen, G, Kaspers, G J L, Groen, R, Ossenkoppele, G & Cloos, J 2021, ' SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia ', Leukemia, vol. 35, no. 9, pp. 2698-2702 . https://doi.org/10.1038/s41375-021-01273-7
    Leukemia, 35(9), 2698-2702. Nature Publishing Group

  9. 9
  10. 10